B-cell acute lymphoblastic leukemia (B-ALL) reflects the malignant counterpart of developing B cells in the bone marrow (BM). Despite tremendous progress in B-ALL treatment, the overall survival of adults at diagnosis and patients at all ages after relapse remains poor. Galectin-1 (GAL1) expressed by BM supportive niches delivers proliferation signals to normal pre-B cells through interaction with the pre-B cell receptor (pre-BCR). Here, we asked whether GAL1 gives non-cell autonomous signals to pre-BCR+ pre-B ALL, in addition to cell-autonomous signals linked to genetic alterations. In syngeneic and patient-derived xenograft (PDX) murine models, murine and human pre-B ALL development is influenced by GAL1 produced by BM niches through pre-BCR-dependent signals, similarly to normal pre-B cells. Furthermore, targeting pre-BCR signaling together with cell-autonomous oncogenic pathways in pre-B ALL PDX improved treatment response. Our results show that non-cell autonomous signals transmitted by BM niches represent promising targets to improve B-ALL patient survival.
Pubmed ID: 37009219 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets
View all literature mentionsThis unknown targets Streptavidin-BD Horizon(tm) PE-CF594
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis unknown targets Rat IgG (H+L)
View all literature mentionsThis unknown targets BLNK, phospho (Tyr84)
View all literature mentionsThis monoclonal targets Syk (pY348)
View all literature mentionsThis polyclonal targets Human Galectin-1
View all literature mentionsThis polyclonal secondary targets IgM (Heavy chain)
View all literature mentionsThis monoclonal targets IgM
View all literature mentionsThis monoclonal targets Integrin β7 chain
View all literature mentionsThis monoclonal targets CD49e (Integrin α5 chain)
View all literature mentionsThis monoclonal targets CD49d (Integrin α4 chain)
View all literature mentionsThis monoclonal targets Human CD45 (LCA; leucocyte common antigen; T200)
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets Human CD19
View all literature mentionsThis unknown targets IgM
View all literature mentionsThis monoclonal targets Ig, λ1, λ2, & λ3 Light Chain
View all literature mentionsThis monoclonal targets Ig, κ light chain
View all literature mentionsThis monoclonal targets CD10
View all literature mentionsThis monoclonal targets Ly-6A/E
View all literature mentionsThis monoclonal targets Mouse Galectin-1
View all literature mentionsThis monoclonal targets Mouse Endomucin
View all literature mentionsThis monoclonal targets Integrin beta 7 chain
View all literature mentionsThis monoclonal targets Ly-51
View all literature mentionsThis unknown targets IgM
View all literature mentionsThis monoclonal targets CD71 (Transferrin Receptor)
View all literature mentionsThis monoclonal targets CD51 (Integrin αV chain)
View all literature mentionsThis monoclonal targets CD49e (Integrin alpha 5)
View all literature mentionsThis monoclonal targets CD49d (Integrin alpha 4)
View all literature mentionsThis unknown targets Mouse CD45
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD45R (B220)
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets Mouse CD44
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD2
View all literature mentionsThis monoclonal targets CD31 (PECAM-1)
View all literature mentionsCell line NALM-6 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions